Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of MTTP mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of MTTP mRNA | increases expression | 18648102
|
C041594 |
4-nonylphenol |
4-nonylphenol results in decreased expression of MTTP mRNA | decreases expression | 17912697
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of MTTP protein | affects expression | 20106945
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of MTTP mRNA | increases expression | 15537571
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of MTTP mRNA | decreases expression | 17912697
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased activity of MTTP protein | decreases activity | 17405876
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased degradation of MTTP protein | increases degradation | 17405876
|
D002331 |
Carnitine |
Carnitine inhibits the reaction [Stavudine results in decreased expression of MTTP mRNA] | decreases expression|decreases reaction | 18299183
|
D002791 |
Cholesterol, Dietary |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of MTTP mRNA | affects cotreatment|decreases expression | 19509184
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of MTTP mRNA | decreases expression | 20106945
|
D018119 |
Stavudine |
Carnitine inhibits the reaction [Stavudine results in decreased expression of MTTP mRNA] | decreases expression|decreases reaction | 18299183
|
D018119 |
Stavudine |
Stavudine results in decreased expression of MTTP mRNA | decreases expression | 18299183
|
D003609 |
Dactinomycin |
Dactinomycin inhibits the reaction [pirinixic acid results in increased expression of MTTP mRNA] | decreases reaction|increases expression | 15537571
|
D003993 |
Dibutyl Phthalate |
Dibutyl Phthalate results in decreased expression of MTTP mRNA | decreases expression | 16835292
|
D004041 |
Dietary Fats |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of MTTP mRNA | affects cotreatment|decreases expression | 19509184
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of MTTP mRNA | increases expression | 16357043
|
D004958 |
Estradiol |
Estradiol results in decreased expression of MTTP mRNA | decreases expression | 20106945
|
D005231 |
Fatty Acids, Unsaturated |
Fatty Acids, Unsaturated results in increased expression of MTTP mRNA | increases expression | 18356535
|
D005632 |
Fructose |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of MTTP mRNA | affects cotreatment|decreases expression | 19509184
|
D018684 |
Glycine Agents |
Glycine Agents results in decreased expression of MTTP mRNA | decreases expression | 16532367
|
C067713 |
lactacystin |
lactacystin results in increased ubiquitination of MTTP protein | increases ubiquitination | 17405876
|
D010126 |
Ozone |
Ozone results in decreased expression of MTTP mRNA | decreases expression | 16183385
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid affects the expression of MTTP mRNA | affects expression | 18281256
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of MTTP mRNA | increases expression | 17681415
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MTTP mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased activity of MTTP protein | increases activity | 15537571
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of MTTP mRNA | increases expression | 16357043 18301758 15375163 15537571
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of MTTP protein | increases expression | 15537571
|
C006253 |
pirinixic acid |
PPARA protein affects the reaction [pirinixic acid results in increased expression of MTTP mRNA] | affects reaction|increases expression | 15537571
|
C006253 |
pirinixic acid |
Dactinomycin inhibits the reaction [pirinixic acid results in increased expression of MTTP mRNA] | decreases reaction|increases expression | 15537571
|
C006253 |
pirinixic acid |
pirinixic acid results in increased activity of MTTP protein | increases activity | 15537571
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of MTTP mRNA | increases expression | 15537571
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of MTTP protein | increases expression | 15537571
|
C003377 |
taxifolin |
taxifolin results in decreased activity of MTTP protein | decreases activity | 15380446
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MTTP mRNA | increases expression | 20106945
|
C009564 |
trilinolein |
trilinolein results in increased expression of MTTP mRNA | increases expression | 18356535
|
C101314 |
trilinolenin |
trilinolenin results in increased expression of MTTP mRNA | increases expression | 18356535
|
D014304 |
Triolein |
Triolein results in increased expression of MTTP mRNA | increases expression | 18356535
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:C535554 |
Abdominal obesity metabolic syndrome |
marker/mechanism |
|
| |
MESH:D000012 |
Abetalipoproteinemia |
marker/mechanism |
|
| |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.62 | 15322242 11752688 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.91 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.04 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.62 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.14 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.14 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
Cholesterol, Dietary |
4.67 | 20157255 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.67 | 15513908 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.75 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Cholesterol, Dietary |
9.94 | 15552841 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
9.94 | 15238619 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.51 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.57 | 16373670 17854713 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.79 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.09 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.09 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.62 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Dactinomycin |
5.31 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.66 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.27 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.27 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.27 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.27 | 17261762 17289903 19861407 12948864 14630087 16675129 17018787 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.27 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.50 | 15516495 17626835 18417511 16777450 18315731 14754758 19059883 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.51 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.23 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.56 | 15700767 16097048 15673190 18705752 3786805 16192424 10355542 16050911 15721981 16011737 16227642 16124888 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.62 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.45 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.45 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
8.45 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
8.45 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.45 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.76 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.57 | 7296757 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.24 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
10.24 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.24 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
10.24 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.97 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
12.41 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.41 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.41 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.01 | 12621046 8697196 16354765 15340226 15668235 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
Fructose |
4.33 | 18504504 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.24 | 15322242 10048152 20055451 |
MESH:D003456 |
Cryptorchidism |
|
Dibutyl Phthalate |
5.23 | 16037377 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.79 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.59 | 11298694 18759878 12868966 8156756 14531868 2524372 11906362 8970840 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.32 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.28 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
4.31 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
4.46 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.46 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.22 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.38 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
8.38 | 6482804 1440618 18289764 9328219 9022650 16192314 11289319 6679447 18692083 7440962 18648102 8291058 9653073 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
8.38 | 6884620 19085960 3786805 16177239 11566570 17522070 6623471 15968718 10915739 7440962 15027814 4309450 10092053 21278145 7179309 9327722 19336974 3732212 7120509 2869522 15998439 16227642 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.38 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Stavudine |
8.03 | 15040536 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.03 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.29 | 18367378 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
10.28 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.28 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.28 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.67 | 16714409 15322242 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.83 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.82 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.05 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
28.06 | 12795759 16239168 12631006 16045604 15959796 19224547 17595544 61145 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
28.06 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
28.06 | 17967931 18296743 19004024 19551842 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
28.06 | 18395287 18641190 19196556 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
28.06 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Stavudine |
28.06 | 18299183 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.23 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.79 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
25.35 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
25.35 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
25.35 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Fructose |
25.35 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
25.35 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.99 | 8708960 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
5.11 | 19165636 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.82 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.36 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.21 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.40 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.19 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.13 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
8.50 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.50 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
13.16 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.16 | 19772884 19176532 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.16 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.80 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Stavudine |
4.33 | 11141242 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.52 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.81 | 16354765 15340226 16959395 18606429 8697196 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
3.67 | 12083418 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.30 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol, Dietary |
9.01 | 10876104 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
9.01 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.99 | 20558911 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.71 | 15752949 14757778 19008412 18360027 18563319 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
8.85 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
8.85 | 15752949 |
MESH:D006951 |
Hyperlipoproteinemias |
|
Fatty Acids, Unsaturated |
6.00 | 18435438 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.71 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.17 | 10903974 |
MESH:D006973 |
Hypertension |
|
Fructose |
8.17 | 14633139 19008412 14568997 14573337 16843071 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.17 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.86 | 15338365 |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.88 | 19799862 19342510 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
7.68 | 20412841 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
7.68 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.68 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
21.63 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
21.63 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
21.63 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
21.63 | 19586609 14573337 18057795 14757778 18563319 17133782 14633139 19008412 18981581 19342510 19799862 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
21.63 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.79 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.21 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.41 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.50 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.50 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
16.22 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
16.22 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
16.22 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
16.22 | 15610895 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.00 | 8812269 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.21 | 16239168 17157831 16943688 17174718 11408273 21278145 17334410 16221502 11903743 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.21 | 18296743 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.06 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.44 | 16033810 12898905 10355542 17714472 12958196 12389079 17721639 17922224 18187930 17944888 18205269 18210741 16116963 14512876 18279442 15338365 12632512 16015684 17766677 17823541 17708605 14716496 18317297 18705752 15052691 12546737 15362042 18006644 17761835 18166357 13678700 18251166 18339082 15673190 17900296 18412020 16011737 17869086 17976157 18395914 16097048 16136751 17640975 18420326 15959796 12632514 12445421 11481614 15876570 17805973 12586293 18277467 15996030 18054572 18263696 15730626 15818738 17698563 18418968 12445418 17525996 16248980 15650968 12609069 17631135 14724832 15123356 20821823 12667390 17481882 18429990 18376398 18156304 18472332 16192424 15925388 17565644 18472094 12741479 17557913 16027843 12649538 15893842 12666154 14716833 18395095 18481824 14620537 14748882 15931870 16638106 15057751 15370692 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carnitine |
6.44 | 14748882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.44 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.44 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.44 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.03 | 16246199 15720792 17285989 15830285 16964402 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
11.09 | 15123358 |
MESH:D017093 |
Liver Failure |
|
Stavudine |
11.09 | 18299183 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.49 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
16.86 | 9163691 18177683 2125692 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
16.86 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Carnitine |
16.86 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
16.86 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
16.86 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
16.86 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
12.94 | 598648 1399818 3712494 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
12.94 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
12.94 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.94 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.23 | 19066396 8266340 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.63 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.66 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
4.66 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
4.66 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.66 | 11884234 19555203 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Carnitine |
5.39 | 16283381 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.42 | 16891317 11807958 11408345 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.25 | 19453300 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
4.63 | 17261469 18497449 17098227 16815490 19165636 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.56 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.87 | 10496685 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.28 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.05 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.84 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.67 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.67 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.63 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.38 | 3581430 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
4.85 | 16946489 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.85 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.50 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.21 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.09 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
15.09 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.09 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.09 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.77 | 6679447 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.73 | 9802331 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
7.18 | 18457598 21332399 16723640 18674790 19632207 17217161 20518802 20132043 11836018 |
MESH:D009765 |
Obesity |
|
Fructose |
7.18 | 18585860 17707055 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
7.18 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.22 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.22 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.79 | 3988306 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.76 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.15 | 19401270 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.26 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
Cholesterol, Dietary |
4.09 | 19014385 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.02 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.91 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.24 | 6228378 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.17 | 18929643 18381685 18007984 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.77 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.34 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.03 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
14.99 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
14.99 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
14.99 | 11896295 11118676 11222880 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.87 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.87 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.35 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.35 | 16740699 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.15 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.56 | 10548101 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.28 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.21 | 3692021 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Dactinomycin |
4.86 | 14601052 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.38 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.94 | 16192470 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.76 | 16684133 16045194 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.67 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.72 | 7505956 3712494 6587162 6582329 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.45 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
4.71 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.71 | 8074119 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.09 | 10091137 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.78 | 14652134 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.75 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.36 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.02 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.55 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.21 | 17120751 |